Trial Profile
A Randomised, Double-Blind, Placebo-Controlled Phase I Study to Assess the Tolerability, Safety, Pharmacokinetic, and Pharmacodynamic Properties of AZD6482, Alone and co-Administered With ASA [aspirin] , After Single Ascending Intravenous Doses to Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs AZD 6482 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- Sponsors AstraZeneca
- 04 Jul 2008 New trial record.